Preprint · CC-BY
via OpenAlex
Boosting cellular NAD+ concentration with nicotinamide mononucleotide prevents Doxorubicin-induced cardiotoxicity
Scholarship@Western (Western University) · 2020
Abstract
Doxorubicin (DOX) is a powerful chemotherapy that functions by interfering with cancer cells’ growth. However, the use of DOX is limited due to its detrimental side effects that can lead to serious cardiovascular complications. Our goal is to determine if nicotinamide mononucleotide (NMN) and histone acetyltransferase (HAT) inhibitors can protect against DOX-induced cardiotoxicity. Our findings revealed that DOX reduced NAD+ concentration and induced damage to H9c2 cells as evidenced by higher caspase-3 activity and lactate dehydrogenase release. Pre-incubation with NMN increased NAD+ concentration and attenuated DOX-induced damage. There was higher cell viability in the NMN pre-incubated group compared to the vehicle treated group in response to DOX. Furthermore, mice pre-treated with NMN had higher ejection fraction and fraction shortening percentage compared to the vehicle treated group. In contrast, pre-incubation with HAT inhibitors failed to protect DOX-treated cells. Thus, our study suggests that NMN may be a potential drug that prevents DOX-induced cardiotoxicity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Dang, R. (2020). Boosting cellular NAD+ concentration with nicotinamide mononucleotide prevents Doxorubicin-induced cardiotoxicity. <em>Scholarship@Western (Western University)</em>. https://openalex.org/W3081748933
Vancouver
Dang R. Boosting cellular NAD+ concentration with nicotinamide mononucleotide prevents Doxorubicin-induced cardiotoxicity. Scholarship@Western (Western University). 2020.
BibTeX
@unpublished{rebecca2020Boosti,
title = {Boosting cellular NAD+ concentration with nicotinamide mononucleotide prevents Doxorubicin-induced cardiotoxicity},
author = {Rebecca Dang},
journal = {Scholarship@Western (Western University)},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
EBioMedicine 2023
Open access · CC-BY
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Biotechnology Journal 2024
Open access · CC-BY
Evaluation of NAD+ precursors for improved metabolism and productivity of antibody‐producing CHO cell
Frontiers in Pharmacology 2016
Open access · CC-BY
Head to Head Comparison of Short-Term Treatment with the NAD+ Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice
Scientific Reports 2026
Open access · CC-BY
Altered NAD metabolism during CNS viral infection and modest immunometabolic effects of NMN in different contexts
PLoS ONE 2009
Open access · CC-BY
Sleep Restriction Increases the Risk of Developing Cardiovascular Diseases by Augmenting Proinflammatory Responses through IL-17 and CRP
Alzheimer s & Dementia 2023
Open access · OA